Overcome Behavioral Biases That Influence Investment Decisions

As a follow up to my recent 10 Valuable Lessons To Achieve Financial Freedom post, I look at how we can overcome behavioral biases that influence and often lead to suboptimal investment decisions. Behavioral biases are a systematic pattern of deviation from rationality in judgment. These biases lead to decisions based on emotions, cognitive errors, [...]

By |December 4th, 2024|Education|Comments Off on Overcome Behavioral Biases That Influence Investment Decisions

Nike Exposure Increased

  Nike (NKE) releases its Q2 and YTD 2025 results on December 19 at which time I intend to revisit this existing holding. The purpose of this brief post, therefore, is merely to disclose that my NKE exposure increased on December 3 with the purchase of 200 shares @ $78.4769 through a 'Core' account within [...]

By |December 3rd, 2024|Equity Investing|Comments Off on Nike Exposure Increased

10 Valuable Lessons To Achieve Financial Freedom

  Becoming financially free does not need to be a daunting undertaking. Here are 10 valuable lessons to achieve financial freedom. Develop a Wealth Mindset If you think you can, you can. If you think you can't, you can't. Becoming financially free starts with having the right mindset. Focus on opportunities rather than limitations. Wealth [...]

By |December 2nd, 2024|Budgeting and Debt, Education|Comments Off on 10 Valuable Lessons To Achieve Financial Freedom

FFJ Portfolio – November 2024

Another month has flown by thus triggering this FFJ Portfolio - November 2024 report; all monthly reports are accessible here. I deployed only ~$94,793 USD during the month and reinvested minimal dividend income. The value of the FFJ Portfolio, however, increased ~$ 35,427 CDN and  ~$ 440,440 USD in one month. None of my existing [...]

By |December 1st, 2024|FFJ Portfolio Holdings|Comments Off on FFJ Portfolio – November 2024

Agilent Valuation Is Insufficiently Compelling

I last reviewed Agilent (A) in this August 23, 2024 post at which time the most current financial information was for Q3 and YTD2024. With the release of Q4 and FY2024 results and FY2025 outlook after the November 25 market close, I revisit this existing holding. Business Overview When I wrote my prior post, A [...]

By |November 27th, 2024|Equity Investing|Comments Off on Agilent Valuation Is Insufficiently Compelling

Zoom Communications – Stock Based Compensation Distorts Free Cash Flow

  The company has been renamed to Zoom Communications, Inc. from Zoom Video Communications, Inc. effective November 25, 2024. Valuing a company based on GAAP and non-GAAP EPS can sometimes lead to poor investment decisions. It is for this reason that I like to look at a company's valuation based on Free Cash Flow (FCF). [...]

By |November 26th, 2024|Equity Investing|Comments Off on Zoom Communications – Stock Based Compensation Distorts Free Cash Flow

Emerson Electric Is A Trapped Dividend King

Companies with an investor base that expects annual dividend increases are, in my opinion, trapped and should be avoided. Emerson Electric (EMR), a Dividend King because it has consistently increased its annual dividend for at least 50 consecutive years, is a good example. I suspect many of us have investment holdings we rarely/never look at. [...]

By |November 25th, 2024|Equity Investing|Comments Off on Emerson Electric Is A Trapped Dividend King

Copart Is A Great Company. Can’t Say The Same For Its Valuation

Copart (CPRT) is a great company but I can't say the same for its valuation. I last reviewed CPRT in my September 5 post at which time, the most currently available financial information was for Q4 and FY2024. Following the November 21 market close, CPRT released its Q1 2025 results thus prompting me to revisit [...]

By |November 24th, 2024|Equity Investing|Comments Off on Copart Is A Great Company. Can’t Say The Same For Its Valuation

Thermo Fisher Danaher Veeva Exposure Increased

Due to family commitments, I have been unable to provide timely updates of my investment activity subsequent to my November 4 Paycom post. The purpose of this brief post is merely to disclose recent increases in my Thermo Fisher, Danaher, and Veeva exposure. Thermo Fisher Scientific (TMO) When I wrote my November 3 TMO post, [...]

By |November 23rd, 2024|Equity Investing|Comments Off on Thermo Fisher Danaher Veeva Exposure Increased

Paycom Is Almost Fairly Valued Following Share Price Surge

In my May 2 2024 post, I disclosed that Paycom's (PAYC) attractive valuation prompted me to acquire additional shares @ ~$163 thus bringing my exposure to 700 shares in a 'Core' account within the FFJ Portfolio. At the time of that post, the most currently available financial information was for Q1 2024 and the Q2 [...]

By |November 4th, 2024|Equity Investing|Comments Off on Paycom Is Almost Fairly Valued Following Share Price Surge
Go to Top